Mary Alissa Willis,Robert J Fox
Mary Alissa Willis
Purpose of review: Many therapeutic advances for relapsing-remitting multiple sclerosis (MS) have occurred in the past 25 years. Although similar advances in disease-modifying therapies have not been realized in progressi...
Mark S Freedman,Carolina A Rush
Mark S Freedman
Purpose of review: Despite the efficacy of current therapies for relapsing forms of multiple sclerosis (MS), there remains a group of patients whose disease fails to respond and warrants a different approach to treatment....
David E Jones
David E Jones
Purpose of review: This article provides an evidence-based approach to the management of patients with early relapsing multiple sclerosis (MS). Recent fin...
Darin T Okuda
Darin T Okuda
Purpose of review: Neurologists are frequently asked to consult on patients with incidentally observed anomalies on brain MRI that may be suggestive of multiple sclerosis (MS). The identification of such findings has impo...
New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders [0.03%]
新的诊断方法、临床病程及治疗目标在多发性硬化及相关障碍中的应用
Stephen C Krieger
Stephen C Krieger
The diagnosis, categorization, and treatment of multiple sclerosis (MS) and other demyelinating diseases have shifted over the past decade, and many of the fundamental principles of MS pathogenesis and clinical course are being rewritten. F...
Patient Management Problem [0.03%]
患者的管理问题
Elizabeth C Finger
Elizabeth C Finger
Coding for Dementia [0.03%]
面向痴呆症的编程教育项目
Bruce H Cohen,Peter D Donofrio
Bruce H Cohen
Amy E Sanders
Amy E Sanders
Informal caregivers (often, but not exclusively, family members) are essential to the clinical care of a patient with dementia. Most caregivers are untrained and unpaid. As a result, caregivers often experience stress caused by the caregivi...
Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients [0.03%]
下一代阿尔茨海默病药物在有症状和高危患者中使用的伦理考量
Serge Gauthier,Pedro Rosa-Neto,Joseph S Kass
Serge Gauthier
This article presents a case in which a patient with mild Alzheimer disease requests a prescription for a newly developed Alzheimer disease drug, after which the patient's daughter inquires about its potential usefulness as a prevention str...